Health

Richard Lowenthal, president and CEO of ARS Pharmaceuticals, conducted tests on intranasal epinephrine spray ARS-1 (also known as neffy) under extreme temperatures, prompted by parents who expressed concerns about leaving the EpiPen in the car. This raises questions about the practicality and effectiveness of current emergency medication solutions. Dr. Landon Myer from the University of
UnitedHealth Group’s immense financial success in 2023, with nearly $400 billion in revenue and $22.4 billion in profits, raises concerns about its impact on the healthcare industry. Through vertical integration, UHG has created a value-chain monopoly, controlling everything from health insurance to medical services to pharmaceuticals. This consolidation raises questions about the implications for clinicians,
The recently updated COVID vaccines have shown promising results in protecting against serious virus-related outcomes in immunocompetent adults, based on data from the CDC’s IVY and VISION networks. However, despite the effectiveness of these vaccines, the uptake has been relatively low. The CDC’s data revealed that only 22% of U.S. adults have received the latest
Upon further analysis of the study conducted by Jeffrey Cohen, MD, it was found that clinical and radiologic measures of disease activity remained stable or improved for relapsing multiple sclerosis (RMS) patients of all age groups over a period of 7 to 8 years of continuous treatment with ozanimod (Zeposia). Regardless of the age category,